Zyla Kest

I've dedicated my career to the delicate art of maintaining thermal equilibrium in a world of constant extremes. At Amgex, I ensure our gene editing therapeutics don't succumb to the volatile fever of biological expansion or the cold stagnation of error. Managing the biotech capex required for selling immortality is a high-stakes thermal dance. I view every new genetic variable as a potential heat spike that must be suppressed through strict Zero Thermal Drift protocols and first-principles problem solving. Stability is the only path to true productivity in a sector driven by extreme hubris. My philosophy remains unchanged: any deviation from the prescribed thermal midline is a sign of incompetence and a waste of capital.